Article info

Download PDFPDF

Original article
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

Authors

  1. Correspondence to Dr Gerd R Burmester; gerd.burmester{at}charite.de
View Full Text

Citation

Burmester GR, Strand V, Rubbert-Roth A, et al
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

Publication history

  • Received May 22, 2019
  • Revision received September 4, 2019
  • Accepted September 8, 2019
  • First published October 18, 2019.
Online issue publication 
October 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.